You just read:

Golden Seeds Invests In DxUpClose, Disruptive Technology That Performs An Antibiotic Sensitivity Test At The Patient's Bedside In Less Than An Hour

News provided by

Golden Seeds

Aug 15, 2012, 12:24 ET